Afficher la notice abrégée

dc.creatorDimitropoulos K., Gravas S.en
dc.date.accessioned2023-01-31T07:56:22Z
dc.date.available2023-01-31T07:56:22Z
dc.date.issued2020
dc.identifier10.1007/s00345-018-02625-2
dc.identifier.issn07244983
dc.identifier.urihttp://hdl.handle.net/11615/73341
dc.description.abstract[No abstract available]en
dc.language.isoenen
dc.sourceWorld Journal of Urologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85059584830&doi=10.1007%2fs00345-018-02625-2&partnerID=40&md5=453e23c84c4b47740a10f1893a2d8850
dc.subjectanticoagulant agenten
dc.subjectfibrinolytic agenten
dc.subjecthumanen
dc.subjecthyperplasiaen
dc.subjectmaleen
dc.subjectprostate hypertrophyen
dc.subjectvolatilizationen
dc.subjectAnticoagulantsen
dc.subjectFibrinolytic Agentsen
dc.subjectHumansen
dc.subjectHyperplasiaen
dc.subjectMaleen
dc.subjectProstatic Hyperplasiaen
dc.subjectVolatilizationen
dc.subjectSpringeren
dc.titleMind the gap: management of benign prostatic obstruction (BPO) surgical candidates on antithromboticsen
dc.typeotheren


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée